The company studied the pill in HIV patients whose virus was already suppressed, including those switching from complex multi-tablet regimens or from a guideline-recommended single-tablet treatment
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.






